Tanezumab (Anti-NGF / bNGF) | Read Reviews & Product Use Citations

Tanezumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia. MW :150 KD.

Purity & Quality Control

≥99

Biological Activity

Description	Tanezumab (Anti-NGF / bNGF) is a human IgG2 monoclonal antibody targeting nerve growth factor (NGF). It can be used in studies of acute and chronic pain such as osteoarthritis, knee and neuralgia, as well as post-herpetic neuralgia. MW :150 KD.

References
[1] Mantyh P, et al. The Journal of Pain, 2009, 10(4): S44.

References

[1] Mantyh P, et al. The Journal of Pain, 2009, 10(4): S44.

Product Details

CAS No.	880266-57-9
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field